IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
SAXagliptin
SAXagliptin
Restricted Medications
Non-Formulary
Brand names:
Onglyza
Form
Strength
TABLET, ORAL
Display
Dipeptidyl Peptidase IV (DDP-4) Inhibitors
Class:
682005
Medication comments:
Per policy, orders for these non-formulary agents will be changed to formulary equivalents.
View all
Non-Formulary Agent
Formulary Equivalent
SAXagliptin (Onglyza) any dose
linagliptin (Tradjenta) 5 mg daily
Last updated:
Aug. 14, 2018
Therapeutic Interchange Policy
linagliptin (Tradjenta)
Look-Alike/Sound-Alike
SAXagliptin confused with SITagliptin
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online